Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Protein phosphatase 1D magnesium-dependent, delta isoform (PPM1D), also known as wild-type p53-induced phosphatase 1 (Wip1), is a phosphatase implicated in oncogenesis.
• PPM1D exhibits oncogenic activity in vitro and in vivo, potentially by inactivating p53, and is overexpressed in various human tumors.

Purpose of the Study:

• To investigate the role of PPM1D's phosphatase activity in its oncogenic function.
• To determine the in vivo consequences of PPM1D deficiency on tumor development, DNA damage response, and longevity.

Main Methods:

• Assessing oncogenic activity using rodent fibroblast transformation assays.
• Analyzing tumor development in PPM1D null mice.
• Evaluating DNA damage response pathways (p53, p38 MAP kinase, Chk1, Chk2) in irradiated PPM1D null and wild-type mice.
• Measuring longevity, serum IGF-1 levels, and body weight in PPM1D null mice.

Main Results:

• The oncogenic function of PPM1D is directly linked to its phosphatase activity.
• PPM1D null mice are resistant to spontaneous tumors throughout their lifespan.
• PPM1D null mice exhibit an enhanced DNA damage response, with increased p53 levels and phosphorylation of key signaling proteins after irradiation.
• Male PPM1D null mice display reduced longevity, lower serum IGF-1, and decreased body weight compared to wild-type controls.

Conclusions:

• PPM1D plays a significant role in cancer development, and its absence confers resistance to tumors.
• PPM1D functions to abrogate the DNA damage response, and its absence leads to a heightened stress response.
• PPM1D influences male longevity and physiological parameters such as body weight and IGF-1 levels.